144 related articles for article (PubMed ID: 2096487)
1. Subcutaneous desmopressin (DDAVP) shortens the prolonged bleeding time in patients with liver cirrhosis.
Cattaneo M; Tenconi PM; Alberca I; Garcia VV; Mannucci PM
Thromb Haemost; 1990 Nov; 64(3):358-60. PubMed ID: 2096487
[TBL] [Abstract][Full Text] [Related]
2. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
[TBL] [Abstract][Full Text] [Related]
3. Desmopressin (DDAVP) for treatment of disorders of hemostasis.
Mannucci PM
Prog Hemost Thromb; 1986; 8():19-45. PubMed ID: 3104987
[TBL] [Abstract][Full Text] [Related]
4. Shortening of bleeding time by 1-deamino-8-arginine vasopressin (DDAVP) in the absence of platelet von Willebrand factor in Gray platelet syndrome.
Pfueller SL; Howard MA; White JG; Menon C; Berry EW
Thromb Haemost; 1987 Dec; 58(4):1060-3. PubMed ID: 3502198
[TBL] [Abstract][Full Text] [Related]
5. Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia.
Mannucci PM; Remuzzi G; Pusineri F; Lombardi R; Valsecchi C; Mecca G; Zimmerman TS
N Engl J Med; 1983 Jan; 308(1):8-12. PubMed ID: 6401193
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders.
Hanebutt FL; Rolf N; Loesel A; Kuhlisch E; Siegert G; Knoefler R
Haemophilia; 2008 May; 14(3):524-30. PubMed ID: 18284449
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of platelet dysfunction and response to DDAVP in patients with congenital platelet function defects. A double-blind placebo-controlled trial.
Rao AK; Ghosh S; Sun L; Yang X; Disa J; Pickens P; Polansky M
Thromb Haemost; 1995 Oct; 74(4):1071-8. PubMed ID: 8560416
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous desmopressin (DDAVP) shortens the bleeding time in uremia.
Viganò GL; Mannucci PM; Lattuada A; Harris A; Remuzzi G
Am J Hematol; 1989 May; 31(1):32-5. PubMed ID: 2705441
[TBL] [Abstract][Full Text] [Related]
9. Study on mechanisms of a haemostatic effect of 1 deamino-8-D-arginine vasopressin (desmopressin) in uraemic patients.
Malyszko J; Pietraszek M; Buczko W; Mysliwiec M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(2):319-24. PubMed ID: 1697836
[TBL] [Abstract][Full Text] [Related]
10. Uremic plasma after infusion of desmopressin (DDAVP) improves the interaction of normal platelets with vessel subendothelium.
Escolar G; Cases A; Monteagudo J; Garrido M; Lopez J; Ordinas A; Revert L; Castillo R
J Lab Clin Med; 1989 Jul; 114(1):36-42. PubMed ID: 2738447
[TBL] [Abstract][Full Text] [Related]
11. Biologic response to subcutaneous and intranasal therapy with desmopressin in a large Amish kindred with Type 2M von Willebrand disease.
Sharthkumar A; Greist A; Di Paola J; Winay J; Roberson C; Heiman M; Herbert S; Parameswaran R; Shapiro A
Haemophilia; 2008 May; 14(3):539-48. PubMed ID: 18312368
[TBL] [Abstract][Full Text] [Related]
12. The clinical significance of different routes of desmopressin (DDAVP) administration in various bleeding disorders.
Mörsdorf S; Köhler M; Leipnitz G; Wenzel E
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):503-7. PubMed ID: 2465962
[TBL] [Abstract][Full Text] [Related]
13. Laboratory response to intranasal desmopressin in women with menorrhagia and platelet dysfunction.
Rose SS; Faiz A; Miller CH; Saidi P; Philipp CS
Haemophilia; 2008 May; 14(3):571-8. PubMed ID: 18312366
[TBL] [Abstract][Full Text] [Related]
14. [Utility of desmopressin in 4 cases of thrombocytopathies associated with giant platelets].
Martínez-Murillo C; Quintana-González S; Ambriz-Fernández R; Arzate-Hernández G; Gutiérrez-Romero M; Gaminio-Gómez E
Rev Invest Clin; 1997; 49(4):281-6. PubMed ID: 9707993
[TBL] [Abstract][Full Text] [Related]
15. Heparin, DDAVP and the bleeding time.
Schulman S; Johnsson H
Thromb Haemost; 1991 Mar; 65(3):242-4. PubMed ID: 2048049
[TBL] [Abstract][Full Text] [Related]
16. [Desmopressin in the treatment of hemorrhagic diathesis].
Haar D; Hasselbalch HC
Ugeskr Laeger; 1995 Nov; 157(48):6713-5. PubMed ID: 8540136
[TBL] [Abstract][Full Text] [Related]
17. Multimeric analysis of von Willebrand factor before and after desmopressin acetate (DDAVP) administration intravenously and subcutaneously in male beagle dogs.
Kraus KH; Turrentine MA; Johnson GS
Am J Vet Res; 1987 Sep; 48(9):1376-9. PubMed ID: 3499101
[TBL] [Abstract][Full Text] [Related]
18. Platelet aggregation at high shear is impaired in patients with congenital defects of platelet secretion and is corrected by DDAVP: correlation with the bleeding time.
Cattaneo M; Pareti FI; Zighetti M; Lecchi A; Lombardi R; Mannucci PM
J Lab Clin Med; 1995 Apr; 125(4):540-7. PubMed ID: 7706911
[TBL] [Abstract][Full Text] [Related]
19. Intranasal administration of demopressin (DDAVP) for type 1 and type 2A von Willebrand disease.
Mohri H; Hashimoto Y; Yamazaki E; Kanamori H; Okubo T
Hematopathol Mol Hematol; 1998; 11(2):109-15. PubMed ID: 9608359
[TBL] [Abstract][Full Text] [Related]
20. DDAVP shortens the prolonged bleeding times of patients with severe von Willebrand disease treated with cryoprecipitate. Evidence for a mechanism of action independent of released von Willebrand factor.
Cattaneo M; Moia M; Delle Valle P; Castellana P; Mannucci PM
Blood; 1989 Nov; 74(6):1972-5. PubMed ID: 2508791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
